Australia approves donanemab, a new drug that slows early Alzheimer’s progression
The Guardian - 22-May-2025Only 10-20% of dementia patients qualify for costly treatment requiring genetic and MRI tests
Alzheimer's Disease
Alzheimer's Disease News
AI uncovers hidden Alzheimer’s trigger and promising treatment
UC San Diego Today - 25-Apr-2025A UC San Diego study reveals how a common gene contributes to spontaneous Alzheimer’s disease
Can senolytics improve brain health? A new hope for Alzheimer’s prevention
Live Forever Club - 09-Mar-2025The drugs showed small benefits in those with cognitive issues
Promising Alzheimer’s drug posdinemab gets FDA fast-track status
Drug Target Review - 04-Feb-2025In Phase IIb trials, plasma biomarkers identify early-stage patients
Arctic Therapeutics secures €26.5M to advance dementia drugs
Longevity Technology - 21-Jan-2025Early trials show reduced stroke risks and slower progression
Alzheimer's Disease Resources
Click on resource name for more details.
The End of Alzheimer’s Program
The First Protocol to Enhance Cognition and Reverse Decline at Any Age written by Dale Bredesen
ALZHEIMER’S STUDY: Lifestyle Changes & Early Alzheimer’s Disease
Dean Ornish highlights how simple lifestyle changes can reverse chronic diseases
Neurobiology of Alzheimer’s disease
Book that covers all major aspects of the disease from basic science to clinical diagnosis and therapy edited by David Dawbarn
The Dementias 2: Blue Books of Neurology Series
Provides rapid access to practical, clinical guidance on the diagnosis and treatment of all forms of dementia edited by John H. Growdon
Alzheimer's Disease Blog Posts
No blog posts found!
